コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 horylation of its substrate Aurora kinase A (AurA).
2 reported migraine was 16% (13% migraine with aura).
3 ine (FHM) is a rare subtype of migraine with aura.
4 graine and in one patient with migraine with aura.
5 support a novel mechanism of activation for AurA.
6 is a key pathogenetic step in migraine with aura.
7 n 4 of 7 patients with otherwise intractable aura.
8 osphorylation is necessary for activation of AurA.
9 re as a therapy for migraine with or without aura.
10 e phenotype in this variant of migraine with aura.
11 that underlie the headache of migraine with aura.
12 d in migraine attacks that begin with visual aura.
13 vascular unit in the development of migraine aura.
14 s cerebral emboli, stroke, and migraine with aura.
15 ree attacks over 3 months while experiencing aura.
16 (CSD) is likely the underlying phenomenon of aura.
17 and efficacy in patients with versus without aura.
18 eatment for some patients with migraine with aura.
19 lmodulin (CaM) binding to multiple motifs on AurA.
20 xtracardiac right-to-left shunts to migraine aura.
21 device for acute treatment of migraine with aura.
22 slow depolarization that underlies migraine aura.
23 rment of noise exclusion in migraine without aura.
24 tween headaches in migraine with and without aura.
25 oglial depolarization implicated in migraine aura.
26 onsidered to be an experimental correlate of aura.
27 tivity, is the most likely cause of migraine aura.
28 e phenotypic diversity of human migraine and aura.
29 is prevalent in patients with migraine with aura.
30 o-left shunts in patients with migraine with aura.
31 accompanied by visual disturbances known as aura.
32 anges may help our understanding of migraine aura.
33 erebral disturbances which subserve migraine aura.
34 TPX2 is a binding partner and activator of AurA.
35 gic migraine than in patients with non-motor aura.
36 derstanding mechanisms subserving the visual aura.
37 clinical characteristics and duration of the aura.
38 hallenging task of capturing patients during aura.
39 redominant sensory phenomenology of migraine aura.
40 n the treatment of migraine with and without aura.
41 l field testing in migraine patients without aura.
42 ed as the cellular correlate of the migraine aura.
43 acute treatment of migraine with and without aura.
44 CSD), the putative mechanism of the migraine aura.
45 electrophysiologic event underlying migraine aura.
46 ura may decrease both headache frequency and aura.
47 re monogenic subtype of common migraine with aura.
49 tesla in 131 patients with migraine (38 with aura; 30.8 +/- 9 years old; 109 women; monthly attack fr
54 fold and activating its associated Aurora-A (AurA), a kinase crucially required for primary cilia dis
56 target Thr-295 of AurA to prevent premature AurA activation during interphase and that phosphorylate
58 tein for Xklp2 (TPX2), a known MT-localizing AurA activator, is an AurA cofactor in centrosome-driven
59 In contrast with previously characterized AurA activators, NPM does not trigger autophosphorylatio
60 no history of migraine, active migraine with aura, active migraine without aura, and past history of
66 al noise-exclusion deficits in migraine with aura and a minor impairment of noise exclusion in migrai
69 ts suggest an essential combined function of AurA and AurB in chromosome segregation and anaphase MT
71 emonstrate that small molecule inhibitors of AurA and HDAC6 selectively stabilize cilia from regulate
72 common migraine phenotypes because of shared aura and headache features, trigger factors, and underly
73 en-labeled pilot study of patients, reducing aura and headache symptoms in 4 of 7 patients with other
76 a new context for evaluating the function of AurA and its inhibitors in normal and cancerous cells.
77 stic types of migraine, termed migraine with aura and migraine without aura, from the International H
79 results suggest a novel relationship between AurA and protein phosphatases during progression through
80 l RNFL thinning in migraine patients without aura and pulsative choroidal blood flow may not be affec
82 o explain the sensory nature of the migraine aura and reveal that sensory cortices are vulnerable in
84 n PFO prevalence in those with migraine with aura and those without (26.8% versus 26.1%; odds ratio 1
85 of intracranial origin such as migraine with aura and why this therapeutic approach may not be effect
87 d surface area abnormalities were related to aura and WMHs (P < .01) but not to disease duration and
88 quire the serine/threonine kinase, Aurora A (AurA), and the centrosomal protein of 192 kDa (Cep192)/s
90 electrophysiological surrogate for migraine aura, and develop severe and prolonged motor deficits af
91 sion, the experimental correlate of migraine aura, and further evaluated the response of spontaneous
92 ng depression, the experimental correlate of aura, and inhibited trigeminal activation in in vivo mig
96 Ten migraine with aura, ten migraine without aura, and ten age-matched headache-free subjects partici
97 e initiation and propagation of the migraine aura, and the visual percept that is produces, remain un
98 atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as a
100 cohort suggest that women with migraine with aura are at increased risk of experiencing TIA or ischem
103 cantly thinner in the migraine patients with aura as compared with both the migraine patients without
105 thermore, an AurA(KS degrees , ACP degrees )-AurA(AT(0)) heterodimer proved to be nonfunctional, wher
108 rst through lower nasal field (69-77% of all auras) before travelling to upper and temporal fields, o
115 (CSD)--an event believed to underlie visual aura--can give rise to activation of nociceptors that in
116 type 1 (FHM1) is a subtype of migraine with aura caused by a gain-of-function mutation in the pore-f
118 tion of Cep192 or specific interference with AurA-Cep192 binding did not prevent AurA oligomerization
121 Familial history of stroke, migraine with aura, circulating antiphospholipid antibodies, discontin
122 depression, the neural correlate of migraine aura, closes the paravascular space and impairs glymphat
123 a known MT-localizing AurA activator, is an AurA cofactor in centrosome-driven spindle assembly.
125 gnificantly more common in the migraine with aura compared to control group (73% vs. 51%, p = 0.02),
128 and its subtypes (presence or absence of an aura) differs between patients whose IS was due to CEAD
129 atio decreased significantly with increasing aura duration and was significantly lower in patients wi
131 la chrysaetos, and turkey vulture, Cathartes aura, during autumn migration across eastern North Ameri
132 risons (migraineurs vs control subjects, the aura effect, the effect of white matter hyperintensities
134 cessive maternal-effect mutation in the gene aura exhibit defects including reduced cortical integrit
135 Patients who suffered from migraine with aura, experienced frequent migraine attacks, had previou
138 ndently as a function of square root of time aura free, leveling by 2 years of stable seizure (aura)
139 nges parallel length of time seizure free or aura free, stabilize after 2 years, and are unrelated to
142 rmed migraine with aura and migraine without aura, from the International Headache Genetics Consortiu
143 arcs, and drug inhibition is consistent with aura function promoting F-actin polymerization and/or st
144 ever, we and others have recently identified AurA functions as diverse as control of ciliary resorpti
146 orty-five patients who had migraines without aura (Group 1), 45 patients who had migraines with aura
147 Group 1), 45 patients who had migraines with aura (Group 2), and 30 healthy participants (control gro
149 or stroke, women who reported migraine with aura had adjusted relative risk (95% confidence interval
154 ion of aPKC, AurA, or a downstream target of AurA, HDAC6, restores ciliogenesis in ceramide-depleted
155 20 patients had comorbid migraine, five with aura; (ii) to identify systematically additional visual
158 the pathophysiological mechanism of migraine aura in human beings, whereas novel animal studies are u
159 stent with the hypothesis that migraine with aura in midlife is associated with late-life vascular di
162 d drawings of his visual percept of migraine aura in real time during more than 1000 attacks of migra
164 a are consistent with what is known of human aura in that sodium ion channels are those predominantly
165 eractivation of the mitotic kinase Aurora-A (AurA) in cancer is associated with genomic instability.
166 d a conditional deletion of Aurora A kinase (AurA) in Cdk1 analogue-sensitive DT40 cells to analyze A
169 epression (CSD), an animal model of migraine aura, induces a rapid and nearly complete closure of the
170 that there can be multiple distinct sites of aura initiation in a given individual and suggest that t
172 modelling, we map two primary regions of CaM-AurA interaction to unfolded sequences in the AurA N- an
176 ning approach indicates that the mutation in aura is associated with a truncation of Mid1 interacting
179 nal analyses revealed that the N-terminus of AurA is not involved in the iteration process, ruling ou
188 e electrophysiological substrate of migraine aura, is enhanced in mice expressing a vascular Notch 3
189 ne type 1, a monogenic migraine variant with aura, is linked to gain-of-function mutations in the CAC
190 ation indeed influenced this timing, because AurA isoforms retaining an intact Thr-295 residue furthe
191 emonstrate that NPM is a strong activator of AurA kinase activity at the centrosome and support a nov
193 HEF1/Cas-L/NEDD9 and the oncogenic Aurora A (AurA) kinase at the basal body of cilia causes phosphory
197 severe headaches that can be preceded by an aura likely caused by cortical spreading depression (SD)
198 fails to complement the originally isolated aura maternal-effect mutation, confirming gene assignmen
200 e contraceptive use in MRM and migraine with aura may decrease both headache frequency and aura.
201 translatable to humans, a subset of migraine auras may belong to a spectrum of hypoperfusion disorder
204 ational Aeronautics and Space Administration Aura Microwave Limb Sounder (MLS) to infer an expression
205 ur studies indicate that maternally provided aura (mid1ip1l) acts during the reorganization of the cy
206 These and other observations suggested that AurA might be involved in pathological conditions, such
210 s (MEM) to explore turkey vulture (Cathartes aura) migration decisions at both hourly and daily scale
211 ntemporaneous measurements of ozone from the Aura-MLS satellite, although the short time period makes
212 atory system (DPMS) between migraine without aura (MwoA) patients and healthy controls (HC), and 2) i
214 8-10.00]; P < .001), either migraine without aura (n = 142; 73.9% vs 26.5%; OR, 7.01 [95% CI, 4.43-11
215 (n = 3243), those with midlife migraine with aura (n = 361) had an increased risk of late-life infarc
216 CI, 4.43-11.09]; P < .001), or migraine with aura (n = 66; 69.7% vs 26.5%; OR, 5.73 [95% CI, 3.07-10.
217 eferential for migraine with aura or without aura, nor were any associations specific for migraine fe
223 ep, the early and acute psychotic state, the aura of temporal lobe epilepsy and hallucinogenic drug s
225 nce with AurA-Cep192 binding did not prevent AurA oligomerization on MTs but abrogated AurA recruitme
231 ith impaired awareness in those experiencing auras only, those with no seizures and those with contin
234 ociations was preferential for migraine with aura or without aura, nor were any associations specific
238 Aqua Atmospheric Infrared Sounder (AIRS) CO, Aura Ozone Monitoring Instrument (OMI) aerosol index, an
240 In migraine, both with aura and without aura, patients' choroid thinning should be considered wh
242 hosphatase would be insufficient to restrict AurA phosphorylation and regulate CDK1 activation, where
243 ous diagnoses, including persistent migraine aura, post-hallucinogen flashback, or psychogenic disord
244 criteria for migraine with aura, with visual aura preceding at least 30% of migraines followed by mod
246 terize and quantify a large number of visual auras recorded by a single individual over nearly two de
247 nt AurA oligomerization on MTs but abrogated AurA recruitment to centrosomes and its activation by ei
252 ional Aeronautics and Space Administration's Aura satellite suggest an approximately 7-10% decrease i
253 e visual disturbance (36%), whereas migraine aura (seven patients) and consumption of illicit drugs (
254 levels, with performance of migraineurs with aura significantly poorer (P < 0.05) than that of contro
255 al seizures with no impairment of awareness (auras, simple partial seizures) continue, if there is a
257 heric Emission Spectrometer (TES) aboard the Aura spacecraft, to investigate aspects of the atmospher
259 ients had been enrolled at one centre in the AURA study, had shown resistance to a previous EGFR TKI,
260 of circle of Willis variants, migraine with aura subjects had a higher burden of variants than contr
261 le of Willis is more common in migraine with aura subjects than controls, and is associated with alte
262 on between the multifaceted phenomenology of aura symptoms and the effects of CSD on the brain has no
263 atients were studied during various forms of aura symptoms induced by hypoxia, sham hypoxia, or physi
264 ATION: These findings suggest that different aura symptoms reflect different types of cerebral dysfun
272 on during interphase and that phosphorylated AurA(Thr-295) acts as a competitor substrate with a CDK1
273 ivity other than PP1 continuously suppresses AurA(Thr-295) phosphorylation during the early embryonic
276 nsitive to OA caused an abnormal increase in AurA(Thr-295) phosphorylation late during interphase tha
278 ep192, through a direct interaction, targets AurA to mitotic centrosomes where the locally accumulati
279 pose that two phosphatases target Thr-295 of AurA to prevent premature AurA activation during interph
280 CSD), the proposed mechanism of the migraine aura, to shape the cortical activity that underlies sens
281 ten begin with warning signs (prodromes) and aura (transient focal neurological symptoms) whose origi
282 our major phenotypes (migraine with multiple auras, transient focal neurological deficits without hea
283 atients who have migraines, with and without aura, using spectral optical coherence tomography (OCT).
284 graine type 1 (FHM1), a severe migraine with aura variant, is caused by mutations in the CACNA1A gene
285 nt of a trans-proteolytic activity assay for Aura virus capsid protease (AVCP) based on fluorescence
286 infarcts 23.0% for women with migraine with aura vs 14.5% for women not reporting headaches; adjuste
287 lence of infarcts for men with migraine with aura vs 21.3% for men not reporting headaches; adjusted
288 ed with migraine with aura, migraine without aura was independently associated with CEAD IS (OR, 1.74
289 on between PFO and migraine (with or without aura) was not modified by diabetes mellitus, hypertensio
290 on documenting the shape and location of the aura wavefront or scotoma in the visual field at one min
292 d from trees, and turkey vultures (Cathartes aura) were the primary scavengers of arboreal carrion, s
293 ypertension and migraine, especially without aura, were confirmed as risk factors for CeAD, in additi
294 ts activation of HDAC6 by cytosolic aPKC and AurA, which promotes acetylation of tubulin in primary c
295 e in patients with episodic migraine without aura who habitually experienced premonitory symptoms dur
296 treating cells exclusively expressing the as-AurA with 1-Na-PP1, we discovered that Aurora A is requi
297 eet international criteria for migraine with aura, with visual aura preceding at least 30% of migrain
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。